Xenon Pharmaceuticals
Biotech · Public
Small molecule selective Kv7 potassium channel opener (azetukalner) for neurological disorders
xenon-pharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 14 granted · 26 pending
- Sector median: 2
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1175 | Unleash Immuno Oncolytics, Inc. | — | $3.0M |
| 1176 | Cessation Therapeutics, Inc. | — | $6.8M |
| 1177 | Dnalite Therapeutics, Inc. | — | $5.6M |
| 1178 | Xenon Pharmaceuticals | — | — |
| 1179 | Pagari Life Science Corp. | — | $678K |
| 1180 | PRIMAL THERAPIES, INC. | — | $677K |
| 1181 | Grace Bio-Labs, Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods Of Administering A Voltage-gated Potassium Channel Openerapplication
- Method For Treating Epilepsygranted
- Methods For Enhancing The Bioavailability And Exposure Of A Voltage-gated Potassium Channel Openerapplication
- Methods For Enhancing The Bioavailability And Exposure Of A Voltage-gated Potassium Channel Openerapplication
- Pyridinylacetamide Derivatives As Sodium Channel Activatorsapplication
- Methods And Uses For Treating Anhedoniaapplication
- Solid State Crystalline Forms Of A Selective Potassium Channel Modulatorgranted
- Pyridinyl Derivatives As Sodium Channel Activatorsapplication
- Methods Of Treating Depressive Disordersapplication
- Pyridine Derivatives And Their Use As Sodium Channel Activatorsapplication
- Methods Of Treating Depressive Disordersgranted
- Conjoint Therapy For Treating Seizure Disordersapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.